Belite Bio, Inc
BLTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,144 | -$31,632 | -$12,648 | -$9,666 |
| Dep. & Amort. | $449 | $399 | $198 | $30 |
| Deferred Tax | $0 | -$4,693 | -$1,911 | $0 |
| Stock-Based Comp. | $8,987 | $3,823 | $1,483 | $1,530 |
| Change in WC | $1,133 | -$2,427 | -$491 | $640 |
| Other Non-Cash | -$3,659 | $4,693 | $1,911 | -$8 |
| Operating Cash Flow | -$29,234 | -$29,837 | -$11,458 | -$7,474 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$116 | -$63 | -$394 | -$74 |
| Net Acquisitions | $0 | $0 | $0 | $18 |
| Inv. Purchases | -$188,265 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $77,844 | $0 | $0 | $0 |
| Other Inv. Act. | -$35 | $0 | $0 | $0 |
| Investing Cash Flow | -$110,572 | -$63 | -$394 | -$56 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $42,236 | $77,189 | $37,990 | -$583 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $41,359 | -$1,230 | -$1,027 | $0 |
| Financing Cash Flow | $83,595 | $75,959 | $36,963 | -$583 |
| Forex Effect | -$269 | $9 | -$366 | -$161 |
| Net Chg. in Cash | -$56,480 | $46,068 | $24,745 | -$8,274 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,157 | $42,089 | $17,344 | $25,618 |
| End Cash | $31,677 | $88,157 | $42,089 | $17,344 |
| Free Cash Flow | -$29,385 | -$29,900 | -$11,852 | -$7,548 |